Sign in

CIK 0002096997 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Kailera Therapeutics, Inc.

Sign in to watch
Ticker
KLRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
508-440-9475
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA, 02451
  1. 4 Open-market buy 10% owner bought 1,562,500 shares at $16.00 ($25,000,000)
  2. 4 Open-market buy Director bought 8,398,438 shares at $16.00 ($134,375,008)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Bylaws or fiscal year change · Other events
  15. 424B4 Offering Prospectus
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. EFFECT Other Notice of Effectiveness
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 2 of 4 · 64 filings